Nakashima Y, Nii T, Ikeda M, Arakawa K
Department of Internal Medicine, Fukuoka University, School of Medicine, Japan.
J Am Coll Cardiol. 1993 Sep;22(3):790-5. doi: 10.1016/0735-1097(93)90192-4.
This study investigated 1) the role of left ventricular diastolic nonuniformity in hypertensive left ventricular diastolic dysfunction, and 2) the effects of a calcium channel antagonist on diastolic nonuniformity in hypertensive and normotensive subjects.
Augmented left ventricular diastolic nonuniformity contributes to diastolic dysfunction in hypertrophic cardiomyopathy. Impaired left ventricular diastolic function with preserved systolic function has been recognized in hypertension. Therefore, abnormal ventricular regional nonuniformity might also be involved in hypertensive diastolic dysfunction in a milder form of hypertrophy.
Thirteen patients with established hypertension underwent radionuclide ventriculography before and after nifedipine administration. Indexes of left ventricular function were derived by computer analysis of the time-activity curve. After a computer subdivided the left ventricle into four regions, a time-activity curve of each region was constructed to determine an index of left ventricular diastolic nonuniformity. This index was calculated as the sum of the absolute values of time difference between global and regional peak filling in the septal, the apical and the lateral region. Ten normotensive subjects were studied for comparison. Echocardiography was performed in both groups.
The two groups were matched for age, gender, heart rate, echocardiographic dimensions and systolic function. In the hypertensive group, left ventricular diastolic filling indexes were impaired, with a negative correlation between peak filling rate and the diastolic nonuniformity index. Although the change in ejection fraction after nifedipine administration was similar in the two groups, the increase in peak filling rate was larger in the hypertensive patients. The diastolic nonuniformity index decreased after nifedipine in the hypertensive but not in the control group. This decrease correlated with improved peak filling rate in the hypertensive group.
In hypertensive patients with preserved systolic function, left ventricular diastolic nonuniformity increases, causing early diastolic dysfunction. Decreased diastolic nonuniformity after pharmacologic intervention contributes to lessened ventricular filling dysfunction, regardless of changes in loading conditions in hypertension. Thus, diastolic nonuniformity is an important determinant of left ventricular filling abnormality and might be a target of pharmacologic intervention in hypertensive patients.
本研究调查了1)左心室舒张期非均匀性在高血压性左心室舒张功能障碍中的作用,以及2)钙通道拮抗剂对高血压和血压正常受试者舒张期非均匀性的影响。
左心室舒张期非均匀性增强会导致肥厚型心肌病的舒张功能障碍。高血压患者已被认识到存在收缩功能正常但舒张功能受损的情况。因此,异常的心室区域非均匀性可能也以较轻的肥厚形式参与了高血压性舒张功能障碍。
13例确诊高血压患者在服用硝苯地平前后接受放射性核素心室造影。通过对时间 - 活性曲线进行计算机分析得出左心室功能指标。在计算机将左心室分为四个区域后,构建每个区域的时间 - 活性曲线以确定左心室舒张期非均匀性指标。该指标计算为间隔、心尖和外侧区域整体与区域峰值充盈时间差的绝对值之和。选取10例血压正常受试者进行对照研究。两组均进行了超声心动图检查。
两组在年龄、性别、心率、超声心动图测量的心室大小和收缩功能方面相匹配。在高血压组中,左心室舒张期充盈指标受损,峰值充盈率与舒张期非均匀性指标呈负相关。尽管两组服用硝苯地平后射血分数的变化相似,但高血压患者峰值充盈率的增加更大。硝苯地平治疗后,高血压组的舒张期非均匀性指标下降,而对照组未下降。高血压组中这种下降与峰值充盈率的改善相关。
在收缩功能正常的高血压患者中,左心室舒张期非均匀性增加,导致舒张早期功能障碍。药物干预后舒张期非均匀性降低有助于减轻心室充盈功能障碍,而与高血压患者负荷条件的变化无关。因此,舒张期非均匀性是左心室充盈异常的重要决定因素,可能是高血压患者药物干预的靶点。